
    
      Single center, bioequivalence, open-label, randomized, 2-way crossover study. 64 + 4 healthy
      adult male or female, smokers and/or non-smokers. Single oral dose (1 x 120 mg) in each
      period with a washout of at least 7 days between doses. Dosing with 240 ml of glucose
      solution (25%).
    
  